Antibodies under a microscope

Ab04183-23.0

TRC105 (Carotuximab)

Target

CD105

Target Alias Names

ENG, END, Endoglin, TRC-105, c-SN6j, Y4-2F1

Isotype/Mimetic

IgG

Animal-Derived Biomaterials Used

No

Sequence Available

No

Original Discovery Method

recombinantly reformatted hybridoma (from pre-2020 immunisation)

Original Discovery Information Provided On Datasheet

Yes

Antibody/Binder Origins

Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression